Pulse Biosciences, Inc.
Every calculator, already run for PLSE
Open the full toolkit →You have the numbers on PLSE. Get the argument.
A written report on which of these readings actually decide the outcome for Pulse Biosciences, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
4 analysts covering PLSEAnalyst Price Target Disagreement for Pulse Biosciences, Inc.
Wall Street's bull case implies +9% from the current price; the bear case implies -34%. A 43% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for PLSE
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and chan…
PLSE — frequently asked
Is PLSE a buy right now?
Wall Street's consensus rating on Pulse Biosciences, Inc. is none across 4 analysts, with a mean price target of $45.25 (-15% vs. the current $53.24). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
When is PLSE's next earnings date?
Pulse Biosciences, Inc. is next scheduled to report earnings around Nov 5, 2026. A full PLSE research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Pulse Biosciences, Inc.?
Analysts covering Pulse Biosciences, Inc. (PLSE) range from a bear-case target of $35.00 to a bull-case high of $58.00, with a mean consensus target of $45.25 across 4 analysts. The spread of $23.00 (43% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Pulse Biosciences, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Pulse Biosciences, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full PLSE research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Pulse Biosciences, Inc., in minutes. 3 free reports included with every account — no credit card required.